EUVIMEDDescubrir EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Therapeutic Plasma Exchange Shows Greater Efficacy Than DFPP in Reducing FT3 and FT4 Levels in Thyrotoxicosis due to Amiodarone‐Induced Thyrotoxicosis Type 2

Marion Gerbal, Olivier Gilly, Marie-Alix Joyeux, Olivier Moranne iD

Journal of Clinical Apheresis · 2025

DOI: 10.1002/jca.70056 ↗

At a glance

Fallbericht in Journal of Clinical Apheresis, 2025. Written by Marion Gerbal and 3 co-authors. Institution: Service Néphrologie-Dialyse-Aphérèse, Hôpital Universitaire de Nîmes, Nîmes, France. Major MEDLINE topics: Amiodarone, Plasma Exchange, Plasmapheresis, Thyrotoxicosis. Cited 3 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Hopital univesitaire de Nimes.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

The American Society for Apheresis (ASFA) recommendations only mention using therapeutic plasma exchange (TPE) to treat drug‐resistant thyroid storms. Double filtration plasmapheresis (DFPP) is a therapeutic apheresis procedure with the advantage of being semi‐selective, making it possible to limit albumin losses and reduce the volume of replacement fluid. However, there have been no studies comparing the efficacy and tolerability of TPE and DFPP for this specific indication. We hereby report the observation of 2 patients treated for thyroid storms due to amiodarone‐induced thyrotoxicosis who were each able to benefit from TPE as well as DFPP sessions, enabling us to compare the purification of free thyroid hormones and tolerance of these two treatments. TPE showed greater efficiency in removing thyroid hormones with the same tolerability as DFPP.

Subjects

MeSH terms (MEDLINE)

AmiodaronePlasma ExchangePlasmapheresisThyrotoxicosisThyroxineTriiodothyronineHumansAnti-Arrhythmia AgentsTreatment Outcome

Author keywords

double filtration plasmapheresistherapeutic plasma exchangethyroid storm

Substances

AmiodaroneAnti-Arrhythmia AgentsThyroxineTriiodothyronine

Authors and institutions

  • Service Néphrologie-Dialyse-Aphérèse, Hôpital Universitaire de Nîmes, Nîmes, France.
  • Service Endocrinologie, Hôpital Universitaire de Nîmes, Nîmes, France.
  • IDESP, Université de Montpellier, Montpellier, France.

ORCID profiles: Olivier Moranne

Funding

  • Hopital univesitaire de Nimes

Cite

APA

Gerbal, M., Gilly, O., Joyeux, M. A., & Moranne, O. (2025). Therapeutic Plasma Exchange Shows Greater Efficacy Than DFPP in Reducing FT3 and FT4 Levels in Thyrotoxicosis due to Amiodarone‐Induced Thyrotoxicosis Type 2. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70056

Vancouver

Gerbal M, Gilly O, Joyeux MA, Moranne O. Therapeutic Plasma Exchange Shows Greater Efficacy Than DFPP in Reducing FT3 and FT4 Levels in Thyrotoxicosis due to Amiodarone‐Induced Thyrotoxicosis Type 2. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70056

BibTeX
@article{Gerbal2025,
  author = {Gerbal, Marion and Gilly, Olivier and Joyeux, Marie-Alix and Moranne, Olivier},
  title = {Therapeutic Plasma Exchange Shows Greater Efficacy Than DFPP in Reducing FT3 and FT4 Levels in Thyrotoxicosis due to Amiodarone‐Induced Thyrotoxicosis Type 2},
  journal = {Journal of Clinical Apheresis},
  year = {2025},
  doi = {10.1002/jca.70056}
}
Start for free →